Subproject 1
Objectives
This subproject will focus on the neurobiology of a-synuclein (aSYN) and LRRK2. In particular, we will address:
- a-SYN aggregation (WP1-3)
- Role of oxidative stress and inflammation in a-SYN-mediated neurodegeneration (WP4)
- Physiological and pathological function of the kinase activity of LRRK2 (WP5)
- Kinase-unrelated pathological effects of LRRK2 (WP6)
- Creation and evaluation of novel rat LRRK2 animal models (WP7)
Workpackages
Workpackage No | Work package title | Lead Participant No | Work Package Leader |
1.1 | Effects of oligomeric alpha-synuclein on cellular homeostasis | University of Aarhus | Poul Henning Jensen |
1.2 | Pathophysiology of secreted a-synuclein species | Biomedical Research Foundation of the Acadamy of Athens | Leonidas Stefanis |
1.3 | Identification of factors that influence a-synuclein oligomerization in cell culture and in vivo | Instituto de Medicina Molecular Lisbon | Tiago Outeiro |
1.4 | Role of oxidative stress and microglial response in a-synuclein-mediated nigral neurodegeneration | Lund University | Deniz Kirik |
1.5 | Examination of the role of LRRK2 in cellular pathways: focus on the kinase activity | Novartis AG | Georgio Rovelli |
1.6 | Beyond kinase activity: Examination of other factors influencing LRRK2 neurotoxicity | The Chancellor, Masters and Scholars of the University of Cambridge | David Rubinsztein |
1.7 | Development of a rat BAC model of LRRK2 | University of Tuebingen | Olaf Riess |